je.st
news
Shire faces tougher task playing defence than AstraZeneca
2014-06-19 10:28:04| Biotech - Topix.net
Drug maker Shire's $35-billion market cap puts it within the sights of a wider range of possible acquirers, such as Amgen or Bristol-Myers Squibb, whereas rival Astra failed to attract another suitor.
Tags: playing
task
faces
defence
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||